07.12.25 -- Cell & Gene Best Of June

With pressure to both accelerate development and prioritize robustness, CGT companies often have limited time for refining manufacturing, analytics, and logistics. Enter the Cell & Gene Therapy Tech Expo: a dynamic slate of industry-leading suppliers showcasing the latest in solutions across Cell Therapy, Gene Therapy, and GMP/Regulatory Compliance via 15-minute interactive presentations. Register for free and make continuous improvement a reality on your path to scalability, cost reduction and, ultimately, enhanced patient access.

Of the root causes of new product launch failure, insufficient relative advantage is by far the most important. Let's take a closer look at lessons we can learn from two key (approved) cell therapies.

At Cell & Gene Live, experts from Mayo Clinic and Astellas highlighted the critical role of partnerships and collaboration in advancing iPSC therapies and regenerative medicine.

Dr. Ali Pashazadeh urges CGT companies to overcome the biotech downturn through integrated strategies, capital discipline, and bold, model-redefining leadership across innovation and commercialization.

Explore the landscape of dermatological drug development through a comprehensive framework for rational early-phase dermatological trials, centered around five foundational pillars.

Experts highlight critical concerns regarding insufficient cold chain infrastructure for cell and gene therapies, emphasizing an urgent need for robust, scalable solutions to meet future demand.

Discover how Germfree Laboratories overcame challenges for the Royal Canadian Mounted Police by designing a mobile lab with advanced biocontainment and state-of-the-art communication systems.